Breast cancer is a heterogeneous group of diseases in which treatment options — and often treatment outcomes — are tied to the presence or absence of molecular markers including the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is breast carcinoma.